Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
This study has been withdrawn prior to enrollment.
Weill Medical College of Cornell University
Information provided by (Responsible Party):
James B. Bussel, Weill Medical College of Cornell University
First received: November 7, 2005
Last updated: November 14, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||April 2009|
|Primary Completion Date:||April 2009 (Final data collection date for primary outcome measure)|